Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
The Journal of Biological Chemistry|July 5, 1991
Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homologP Lollar, E T ParkerBritish Journal of Cancer|November 1, 1979
Host treatments affecting artificial pulmonary metastases: interpretation of loss of radioactively labelled cells from lungsJ M Brown, E T ParkerThe Journal of Biological Chemistry|November 25, 1992
Coagulant properties of hybrid human/porcine factor VIII moleculesP Lollar, E T Parker, P J FayJournal of Thrombosis and Haemostasis : JTH|December 3, 2017
Identification of aggregates in therapeutic formulations of recombinant full-length factor VIII products by sedimentation velocity analytical ultracentrifugationJ F Healey, E T Parker, P LollarBlood|June 15, 1990
Production of monoclonal antibodies that detect Hodgkin's high molecular weight transforming growth factor-betaS R Newcom, L H Muth, E T ParkerThe Journal of Biological Chemistry|October 28, 1994
Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activatorR T Barrow, E T Parker, S Krishnaswamy, et al.Biochemistry|August 5, 1997
Subunit structure and function of porcine factor Xa-activated factor VIIIE T Parker, J Pohl, M N Blackburn, et al.Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIIIE T Parker, H N Craddock, R T Barrow, et al.The Journal of Biological Chemistry|February 25, 1994
Isolation and characterization of thrombin-activated human factor VIIIJ E Curtis, S L Helgerson, E T Parker, et al.The Journal of Biological Chemistry|August 25, 1992
Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesiclesE J Duffy, E T Parker, V P Mutucumarana, et al.Pageof 2